{{Rsnum
|rsid=10508293
|Chromosome=10
|Orientation=minus
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene=AKR1C3
|position=5141137
|Gene_s=AKR1C3
|Assembly=GRCh37.p10
|GenomeBuild=37.5
|dbSNPBuild=138
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 4.4 | 25.7 | 69.9
| HCB | 41.6 | 45.3 | 13.1
| JPT | 66.4 | 31.0 | 2.7
| YRI | 2.0 | 19.0 | 78.9
| ASW | 3.5 | 22.8 | 73.7
| CHB | 41.6 | 45.3 | 13.1
| CHD | 40.7 | 44.4 | 14.8
| GIH | 23.8 | 46.5 | 29.7
| LWK | 1.8 | 30.0 | 68.2
| MEX | 20.7 | 55.2 | 24.1
| MKK | 1.9 | 32.1 | 66.0
| TSI | 3.9 | 27.5 | 68.6
| HapMapRevision=28
}}{{PMID Auto
|PMID=24633940
|Title=Genetic polymorphisms in oxidative stress-related genes are associated with outcomes following treatment for aggressive B-cell non-Hodgkin lymphoma
}}

{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}